ArticleRenal failure2025
Association between the atherogenic index of plasma and chronic kidney disease: an evaluation of an adult population of American patients with diabetes mellitus.
Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- NLRP3 Inflammasome Activation and Atherogenic Lipid Profile in Hemodialysis Patients.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2026Article
- Association between the atherogenic index of plasma and prognosis in kidney transplant recipients: a retrospective cohort study.International urology and nephrology · 2026Article
- Atherogenic Index of Plasma for the Prediction of Delirium in ICU Patients: A Retrospective Cohort Study Based on the MIMIC-IV Database.Brain and behavior · 2026Article
- Linear association between atherogenic index of plasma and diabetic kidney disease: evidence from a large clinical cohort and NHANES.Frontiers in nutrition · 2026Article
- Developing and validating a clinlabomics-based machine-learning model for early detection of occult diabetic kidney disease: implications for primary care screening.Frontiers in endocrinology · 2026Article
- Novel obesity biomarkers as mortality predictors in individuals with CKD: a comparative analysis with traditional anthropometric measures.Renal failure · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atherogenic index of plasma (AIP), as a low-cost and easily accessible biomarker of inflammation, has attracted much attention in various disease studies in recent years. Specifically, existing research has suggested AIP index is an important marker of insulin resistance and a significant risk factor for cardiovascular disease, indicating its potential relevance to diabetic complications. However, few studies have investigated association between AIP and chronic kidney disease (CKD) in the diabetic population. This study aimed to investigate the relationship between AIP and the risk of CKD in patients with diabetes mellitus. A cross-sectional analysis of 2005-2016 National Health and Nutrition Examination Survey data was conducted. AIP was categorized into quartiles, and weighted multivariate logistic regression and restricted cubic splines were used to assess associations. Subgroup analyses and interaction tests were performed. Among 2726 diabetic patients, 38.51% had CKD. After adjusting for confounders, AIP was positively associated with CKD (OR = 1.31, 95% CI 1.04 to 1.65,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.